Oncternal Therapeutics Inc (ONCT): Outperform rating. Analyst Oppenheimer...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Oncternal Therapeutics Inc (ONCT)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	256
Boards Moderated	0
Alias Born	08/12/2022

Re: None

Tuesday, 08/16/2022 2:45:07 PM

Tuesday, August 16, 2022 2:45:07 PM

Outperform rating. Analyst Oppenheimer Hartaj Singh has a $14.00 price target over 1000% upside
https://seekingalpha.com/news/3679856-oppenheimer-sees-around-62-rise-in-shares-of-oncternal-therapuetics

ZILO-301: Phase III study of zilovertamab + ibrutinib Abbie blockbuster drug they bought from pharmacyclics for 21 Billion dollars in R/R MCL

Onct Pipeline
https://www.oncternal.com/pipeline

August 2022 Onct Presentation
https://investor.oncternal.com/static-files/f7628e1c-42c5-4c8a-8247-e910ad5555c4

ONCT Corporate Presentation August 2022
Corporate Highlights

ZILOVERTAMAB: POTENTIALLY FIRST-IN-CLASS MONOCLONAL ANTIBODY TARGETING ROR1
• Safety and efficacy results for zilovertamab + ibrutinib in patients with MCL/CLL compare favorably to historical single-
agent ibrutinib[/b]
• Encouraging efficacy results in patients with p53 mutated CLL, with PFS of 100% at 24 and 30 months ORR 85% (23/27)
• CR rate 41% (11/27)
• Agreement with U.S. FDA on Phase 3 global registrational study design for the treatment of patients with R/R MCL

• Subject of large pharma acquisitions.
ROR1-ADCs: Merck 2.75Billion (VelosBio), Boehringer (NBE 1.5 Billion

Onct has 10 cutting edge molecules in their deep pipeline.

Take over target at 60 million market cap Insiders & institutions own 35% of the 50 Million shares cash runway well into the first half of 2024

Is one of most undervalued small cap biotech's.

$ONCT

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ONCT News

Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:49:42 PM
Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 09/12/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:30:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:17:40 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/08/2024 09:42:09 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:20:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:02:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:05:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:00:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:31:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:01:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:01:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 08:59:48 PM

More ONCT News

InvestorsHub NewsWire

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow